- Home
- PED vs CTOR Comparison
PED vs CTOR Comparison
Compare PED & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- CTOR
- Stock Information
- Founded
- PED N/A
- CTOR 2021
- Country
- PED United States
- CTOR United States
- Employees
- PED N/A
- CTOR N/A
- Industry
- PED Oil & Gas Production
- CTOR
- Sector
- PED Energy
- CTOR
- Exchange
- PED Nasdaq
- CTOR NYSE
- Market Cap
- PED 48.8M
- CTOR 52.2M
- IPO Year
- PED N/A
- CTOR N/A
- Fundamental
- Price
- PED $0.53
- CTOR $0.87
- Analyst Decision
- PED Strong Buy
- CTOR Strong Buy
- Analyst Count
- PED 3
- CTOR 2
- Target Price
- PED $1.83
- CTOR $4.50
- AVG Volume (30 Days)
- PED 70.4K
- CTOR 65.0K
- Earning Date
- PED 05-19-2025
- CTOR 05-21-2025
- Dividend Yield
- PED N/A
- CTOR N/A
- EPS Growth
- PED 921.21
- CTOR N/A
- EPS
- PED 0.20
- CTOR N/A
- Revenue
- PED $39,553,000.00
- CTOR N/A
- Revenue This Year
- PED N/A
- CTOR N/A
- Revenue Next Year
- PED $5.99
- CTOR N/A
- P/E Ratio
- PED $2.71
- CTOR N/A
- Revenue Growth
- PED 28.49
- CTOR N/A
- 52 Week Low
- PED $0.47
- CTOR $0.55
- 52 Week High
- PED $1.10
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- PED 40.67
- CTOR N/A
- Support Level
- PED $0.51
- CTOR N/A
- Resistance Level
- PED $0.58
- CTOR N/A
- Average True Range (ATR)
- PED 0.03
- CTOR 0.00
- MACD
- PED 0.01
- CTOR 0.00
- Stochastic Oscillator
- PED 40.13
- CTOR 0.00
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.